Cargando…

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?

Urothelial bladder cancer is a complex disease displaying a landscape of heterogenous molecular subtypes, mutation profiles and clinical presentations. Diagnosis and surveillance rely on flexible cystoscopy which has high accuracy, albeit accompanied by a high-cost burden for healthcare providers an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Humayun-Zakaria, Nada, Ward, Douglas G., Arnold, Roland, Bryan, Richard T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Expectant Management in Genitourinary Malignancies (Prostate, Bladder, Kidney)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261432/ https://www.ncbi.nlm.nih.gov/pubmed/34295762 http://dx.doi.org/10.21037/tau-20-1327

Ejemplares similares

Expectant management in genitourinary malignancies (prostate, bladder, kidney)
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future?
por: Roobol, Monique J.
Publicado: (2021)

Endoscopic surveillance for bladder cancer: a systematic review of contemporary worldwide practices
por: Russell, Beth, et al.
Publicado: (2021)

Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer—a systematic review
por: Nayak, Arvind, et al.
Publicado: (2021)

Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients
por: Crump, R. Trafford, et al.
Publicado: (2021)

The need for research methodology to improve acceptability of long-term surveillance for cancer
por: Kinsella, Netty, et al.
Publicado: (2021)

Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2021)

Factors that influence patients’ views on treatment decision-making in localised kidney cancer
por: Beyer, Katharina, et al.
Publicado: (2021)

Surveillance for low-risk kidney cancer: a narrative review of contemporary worldwide practices
por: Cui, Helen Wei, et al.
Publicado: (2021)

The need for core outcome sets in urological cancer research
por: MacLennan, Steven, et al.
Publicado: (2021)

Active surveillance for prostate cancer
por: Shill, Daniela K., et al.
Publicado: (2021)

Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review
por: Giudici, Nicola, et al.
Publicado: (2021)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
por: Humayun-Zakaria, Nada, et al.
Publicado: (2019)

Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging
por: Delli Pizzi, Andrea, et al.
Publicado: (2022)

Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry
por: Peak, Taylor, et al.
Publicado: (2023)

Combination therapies involving checkpoint-inhibitors for treatment of urothelial carcinoma: a narrative review
por: Schulz, Gerald B., et al.
Publicado: (2021)

Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature
por: Gust, Kilian M., et al.
Publicado: (2021)

The Use of Urine Mycobacterium tuberculosis Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guérin Therapy in Patients with Non–muscle‑invasive Bladder Cancer
por: Muto, Satoru, et al.
Publicado: (2021)

Treatment options for advanced urothelial cancer after progression on chemotherapy and immune checkpoint inhibitors: a literature review
por: Koshkin, Vadim S., et al.
Publicado: (2021)

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
por: Ghali, Fady, et al.
Publicado: (2022)

Xpert® bladder cancer detection as a diagnostic tool in upper urinary tract urothelial carcinoma: preliminary results
por: D’Elia, Carolina, et al.
Publicado: (2022)

Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment
por: Besançon, Marjorie, et al.
Publicado: (2022)

The Significant Role of Depression in Elderly Patients with Bladder Cancer
por: Oserowsky, Alexander, et al.
Publicado: (2021)

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
por: Tan, Wei Shen, et al.
Publicado: (2023)

Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
por: Schmidt, Bogdana, et al.
Publicado: (2022)

Outcomes of Patients with Advanced Urothelial Carcinoma after Anti–programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational Study
por: Rezazadeh Kalebasty, Arash, et al.
Publicado: (2022)

Value of radiomics in differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma
por: Li, Yajuan, et al.
Publicado: (2019)

Multivariate analysis of CT imaging, laboratory, and demographical features for prediction of acute kidney injury in COVID-19 patients: a Bi-centric analysis
por: Hectors, Stefanie J., et al.
Publicado: (2020)

Renal biopsies performed before versus during ablation of T1 renal tumors: implications for prevention of overtreatment and follow-up
por: Widdershoven, Christiaan V., et al.
Publicado: (2020)

Prediction of burden and management of renal calculi from whole kidney radiomics: a multicenter study
por: Homayounieh, Fatemeh, et al.
Publicado: (2020)

Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease
por: Kline, Timothy L., et al.
Publicado: (2020)

(18)F-FDG texture analysis predicts the pathological Fuhrman nuclear grade of clear cell renal cell carcinoma
por: Zhang, Linhan, et al.
Publicado: (2021)

Diffusion-weighted MRI and histogram analysis: assessment of response to neoadjuvant chemotherapy in nephroblastoma
por: Hötker, Andreas M., et al.
Publicado: (2021)

Three-dimensional static-fluid MR urography with gradient- and spin-echo (GRASE) at 3.0T: comparison of image quality and diagnostic performance with respiratory-triggered fast spin-echo (FSE)
por: Wang, Wei, et al.
Publicado: (2022)

A MRI-based radiomics nomogram for evaluation of renal function in ADPKD
por: Li, Xiaojiao, et al.
Publicado: (2022)

Automated measurement of total kidney volume from 3D ultrasound images of patients affected by polycystic kidney disease and comparison to MR measurements
por: Jagtap, Jaidip M., et al.
Publicado: (2022)

Comparison of PSA density and lesion volume strategies for selecting men with equivocal PI-RADS 3 lesions on bpMRI for biopsies
por: Kortenbach, Karen-Cecilie, et al.
Publicado: (2022)

Structured reporting in radiology enables epidemiological analysis through data mining: urolithiasis as a use case
por: Jorg, Tobias, et al.
Publicado: (2023)

Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
por: Rezaee, Michael E., et al.
Publicado: (2021)

Massive inguino-scrotal herniation of urinary bladder in an infant (scrotal cystocele)—case report()()
por: Foladi, Naqibullah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q2mo58j3n4hdmceh42v4gsgb2h